Life science investor Novo Holdings expanding to Asia, sets up SG office

Life science investor Novo Holdings, the venture capital arm of Novo Nordisk Foundation, is expanding into Asia and setting up an office in Singapore, the company said in a statement Thursday.

Novo Holdings said it has tapped Amit Kakar to head the Asian outpost and lead investments and partnerships in China, Japan, Singapore and the rest of Southeast Asia.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter